A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
The purpose of this study is to test any good and bad effects of the combination of LEE011 with everolimus on the participant and the cancer.
Neuroendocrine Tumors
DRUG: LEE011|DRUG: everolimus
Progression Free Survival (PFS), using RECIST v1.1, 12 months
The purpose of this study is to test any good and bad effects of the combination of LEE011 with everolimus on the participant and the cancer.